Jacobs Levy Equity Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Buy |
+23,530
| New | +$220K | ﹤0.01% | 974 |
|
|
2022
Q2 | – | Sell |
-27,664
| Closed | -$481K | – | 1080 |
|
|
2022
Q1 | $481K | Buy |
+27,664
| New | +$481K | ﹤0.01% | 869 |
|
|
2020
Q2 | – | Sell |
-81,248
| Closed | -$891K | – | 1143 |
|
|
2020
Q1 | $891K | Sell |
81,248
-20,704
| -20% | -$227K | 0.01% | 654 |
|
|
2019
Q4 | $895K | Buy |
101,952
+22,208
| +28% | +$195K | 0.01% | 707 |
|
|
2019
Q3 | $596K | Buy |
79,744
+47,712
| +149% | +$357K | 0.01% | 695 |
|
|
2019
Q2 | $298K | Buy |
32,032
+15,832
| +98% | +$147K | ﹤0.01% | 815 |
|
|
2019
Q1 | $85K | Sell |
16,200
-26,739
| -62% | -$140K | ﹤0.01% | 937 |
|
|
2018
Q4 | $191K | Sell |
42,939
-20,976
| -33% | -$93.3K | ﹤0.01% | 893 |
|
|
2018
Q3 | $516K | Buy |
63,915
+23,100
| +57% | +$186K | 0.01% | 772 |
|
|
2018
Q2 | $287K | Buy |
+40,815
| New | +$287K | ﹤0.01% | 894 |
|